Curing metastatic cancer: lessons from testicular germ-cell tumours
- PMID: 12835671
- DOI: 10.1038/nrc1120
Curing metastatic cancer: lessons from testicular germ-cell tumours
Abstract
Most metastatic cancers are fatal. More than 80% of patients with metastatic testicular germ-cell tumours (TGCTs), however, can be cured using cisplatin-based combination chemotherapy. Why are TGCTs more sensitive to chemotherapeutics than most other tumour types? Answers to this question could lead to new treatments for metastatic cancers.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
